Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Odyssey Health (ODYY) Cash & Equivalents (2016 - 2021)

Odyssey Health (ODYY) has 8 years of Cash & Equivalents data on record, last reported at $1.4 million in Q2 2021.

  • For Q2 2021, Cash & Equivalents rose 5073.13% year-over-year to $1.4 million; the TTM value through Apr 2021 reached $1.4 million, up 5073.13%, while the annual FY2020 figure was $556584.0, 233.09% up from the prior year.
  • Cash & Equivalents reached $1.4 million in Q2 2021 per ODYY's latest filing, up from $63072.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.4 million in Q2 2021 and bottomed at $328.0 in Q2 2019.
  • Average Cash & Equivalents over 5 years is $146319.9, with a median of $9786.0 recorded in 2017.
  • Peak YoY movement for Cash & Equivalents: tumbled 97.1% in 2018, then soared 42744.87% in 2019.
  • A 5-year view of Cash & Equivalents shows it stood at $11529.0 in 2017, then crashed by 91.28% to $1005.0 in 2018, then soared by 10081.09% to $102320.0 in 2019, then skyrocketed by 186.12% to $292756.0 in 2020, then soared by 370.78% to $1.4 million in 2021.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $1.4 million in Q2 2021, $63072.0 in Q1 2021, and $292756.0 in Q4 2020.